A Phase 1 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Advanced Solid Tumors
Clinical trial NCT06394414 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06394414
- Sponsor
- MediLink Therapeutics (Suzhou) Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-17
- Primary completion
- 2027-04-29
- Enrollment
- 187
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.